Jubilant Ingrevia Ltd
Company Profile
Business description
Jubilant Ingrevia Ltd is a life science products and solutions provider in the chemicals industry. It serves Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial customers with its customized products and solutions. Its segments are Specialty chemicals, Nutrition & Health solutions, and Chemical Intermediates. The maximum revenue for the company is generated from its Specialty chemicals segment, which includes Bio-Pyridine & Bio-Picolines, Fine chemicals, Agro chemicals, Custom development and manufacturing organization, Microbial control solutions.. Geographically, it derives key revenue from India and the rest from the Americas and Europe, China, and the Rest of the world.
Contact
1-A
Sector 16-A
NoidaUP201301
INDT: +91 1204361502
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 March 2026
Employees
3,425
Stocks News & Analysis
stocks
Avoid this overpriced ASX share
stocks
Markets brief: How will AI affect economic moats? Morningstar’s take on the new paradigm
stocks
Baidu: Moat downgraded to none from wide; AI segment growth to offset search decline in long \run
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,924.20 | 83.70 | 0.95% |
| CAC 40 | 7,997.73 | 82.37 | 1.04% |
| DAX 40 | 23,808.32 | 398.95 | 1.70% |
| Dow JONES (US) | 47,740.80 | 239.25 | 0.50% |
| FTSE 100 | 10,371.02 | 121.50 | 1.19% |
| HKSE | 25,959.90 | 202.61 | 0.79% |
| NASDAQ | 22,695.95 | 308.27 | 1.38% |
| Nikkei 225 | 54,248.39 | 1,372.45 | -2.47% |
| NZX 50 Index | 13,094.37 | 523.52 | -3.84% |
| S&P 500 | 6,795.99 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,692.60 | 90.30 | 1.05% |
| SSE Composite Index | 4,123.14 | 26.54 | 0.65% |